A national survey of valganciclovir dosing strategies in pediatric organ transplant recipients.
Suhail A ShaikhNatalia Jasiak-PanekJeong M ParkPublished in: Clinical transplantation (2018)
Less than two-thirds of centers utilize the FDA-approved daily dosing regimen with various methods of CrCl calculation and serum creatinine assay measurements used. More retrospective and prospective studies with clinical outcomes associated with VCGV dosing strategies are warranted to determine the most appropriate prophylaxis and treatment strategies for CMV.